伴骨侵犯的基底细胞癌:系统综述与汇总生存分析
该系统综述与汇总生存分析纳入70篇文献共101例伴骨侵犯的基底细胞癌患者,多数为位于面部高危区域的大体积、被忽视肿瘤。5年时,切缘阴性后复发风险概率为30%,切缘状态不明时疾病进展或死亡风险为72.1%,BCC相关死亡风险为18.2%,总死亡概率为20.7%。
要点
- 伴骨侵犯的BCC多为面部高危区大肿瘤,需警惕局部侵袭性。
- 5年BCC相关死亡风险18.2%,总死亡概率20.7%。
- 切缘阴性后5年复发风险概率仍达30%。
核心结论
- 伴骨侵犯的基底细胞癌疾病进展率高、5年生存率欠佳,预后较差,凸显早期发现与治疗的重要性。
研究设计与样本
- 系统综述与汇总生存分析,纳入70篇文献中101例伴骨侵犯的基底细胞癌患者,含病例报告与病例系列。
主要发现
- 伴骨侵犯的BCC肿瘤最常见为位于面部高危区域的大体积、被忽视肿瘤。
- 5年时,切缘阴性后疾病复发风险概率为30%。
- 5年时,切缘状态不明者疾病进展或死亡风险为72.1%。
- 5年时,BCC相关死亡风险为18.2%,总死亡概率为20.7%。
临床怎么用
- 对伴骨侵犯的BCC应重视早期发现与治疗,并关注切缘状态对复发和进展风险的影响。
局限性
- 依赖病例报告与病例系列获取个体患者数据,可能引入选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although basal cell carcinoma (BCC) tends to follow an indolent course, some tumors can exhibit locally aggressive behavior and invade into bone. OBJECTIVE: To analyze all published demographic, clinical, and treatment data on recurrence patterns, disease progression, disease-specific death, and overall mortality of BCC with bone invasion. METHODS: A systematic review and pooled-survival analysis was performed, including case reports and case series of BCC with bone invasion. RESULTS: The study included 101 patients from 70 publications. BCC tumors invading into bone were most often large, neglected tumors located in high-risk face areas. At 5 years, patients had a 30% risk probability of disease recurrence (after negative margins), a 72.1% risk of disease progression or death (with ambiguous margin status), an 18.2% risk of BCC-related death, and a 20.7% overall probability of death. LIMITATIONS: Limitations include the reliance on case reports and series for individual patient data, which has the potential to introduce selection bias. CONCLUSION: The high rate of disease progression and suboptimal 5-year survival rate highlights the poor prognosis of BCC with bone invasion and further underscores the importance of early detection and treatment.
引用
- Russell E, Udkoff J, Knackstedt T, et al. Basal cell carcinoma with bone invasion: A systematic review and pooled survival analysis. J Am Acad Dermatol. 2021. PMID: 34273459. doi:10.1016/j.jaad.2021.06.889
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。